To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HNRNPLandECH1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
746 representative clones for gene HNRNPLandECH1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX331235 Neuroblastoma Cot 10-normalized .a 1 to 831 1 to 830       830/830
(100 %)
2 diff
(99.8 %id)
BM919566 pooled pancreas and spleen .a 6 to 919 20 to 937   tiling clone,   918/1006
(91 %)
20 diff
(98.1 %id)
BI767941 pooled lung and spleen .a 26 to 810 1 to 785       785/785
(100 %)
6 diff
(99.3 %id)
TI_57184032   .a 26 to 810 61 to 845       785/845
(92 %)
6 diff
(99.3 %id)
CF122825 CNCAP(3)T-225 cell line, Prostate .a 120 to 749 8 to 636       629/636
(98 %)
6 diff
(99.1 %id)
TI_154182534   .a 120 to 912 64 to 849       786/788
(99 %)
10 diff
(98.8 %id)
BX441588 brain, fetal brain .a 225 to 963 1 to 734       734/853
(86 %)
8 diff
(99.1 %id)
BM755038 stomach .a 348 to 850 1 to 503       503/503
(100 %)
4 diff
(99.3 %id)
CA454747   .a 350 to 1009 1 to 672   tiling clone,   672/971
(69 %)
17 diff
(98.3 %id)
BU172477 melanotic melanoma, cell line, skin .a 434 to 1108 32 to 708   tiling clone,   677/1037
(65 %)
20 diff
(98.1 %id)
BM193364 leukopheresis .a 470 to 809 1 to 339       339/339
(100 %)
9 diff
(97.4 %id)
AY927476   .a 1030 to 1992 963 to 1   tiling clone, Submitted on the opposite strand 963/963
(100 %)
0 diff
(100 %id)
CN278701 embryonic stem cells, cell lines H1, H7, andH9 .a 1074 to 1494 1 to 421       421/421
(100 %)
2 diff
(99.6 %id)
AA324087 brain, cerebellum .a 1108 to 1434 1 to 327       327/327
(100 %)
1 diff
(99.7 %id)
BF095913 uterus_tumor .a 1113 to 1324 15 to 226       212/226
(93 %)
8 diff
(96.5 %id)
EC495352 Prostate .a 1146 to 1242 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
EC538696 Prostate .a 1146 to 1242 1 to 98       98/98
(100 %)
4 diff
(96.0 %id)
EC538760 Prostate .a 1146 to 1242 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
N50283 multiple sclerosis lesions .a 1169 to 1503 1 to 335       335/335
(100 %)
1 diff
(99.8 %id)
AW899153 nervous_normal .a 1171 to 1489 11 to 327       317/332
(95 %)
8 diff
(97.6 %id)
BE699582 nervous_normal .a 1171 to 1488 323 to 6       318/325
(97 %)
1 diff
(99.7 %id)
AA092124   .a 1183 to 1382 1 to 200       200/200
(100 %)
5 diff
(97.5 %id)
CA406987 adipose .a 1591 to 1952 4 to 365       365/365
(100 %)
0 diff
(100 %id)
FN080261 breast carcinoma .a 1624 to 1692 69 to 1     Submitted on the opposite strand 69/70
(98 %)
0 diff
(100 %id)
FN103801 breast carcinoma .a 1663 to 1760 1 to 98       98/98
(100 %)
0 diff
(100 %id)
BE177548 head_neck .a 1675 to 1984 310 to 3     Submitted on the opposite strand 308/321
(95 %)
3 diff
(99.1 %id)
FN141136 breast carcinoma .a 1754 to 1850 1 to 93       93/96
(96 %)
8 diff
(91.7 %id)
FN146300 breast carcinoma .a 1786 to 1882 1 to 97       97/97
(100 %)
0 diff
(100 %id)
FN086685 breast carcinoma .a 1802 to 1873 69 to 1     Submitted on the opposite strand 69/69
(100 %)
3 diff
(95.7 %id)
BI461733 testis .b 1 to 703 1 to 697   tiling clone,   697/697
(100 %)
17 diff
(97.6 %id)
CB990286 Human Placenta, placenta .b 354 to 996 29 to 676       648/823
(78 %)
16 diff
(98.1 %id)
CB990414 Human Placenta, placenta .b 354 to 1001 29 to 685       657/820
(80 %)
31 diff
(96.3 %id)
CF593665 Human Placenta, placenta .b 354 to 996 30 to 675       646/853
(75 %)
23 diff
(97.4 %id)
DA999683 breast, tumor tissue .b 354 to 623 2 to 281   capped   280/280
(100 %)
10 diff
(96.5 %id)
CB995393 placenta, pre-eclamptic placenta .b 357 to 921 28 to 593       566/913
(61 %)
42 diff
(95.4 %id)
CB994293 placenta, pre-eclamptic placenta .b 357 to 980 28 to 658       631/839
(75 %)
20 diff
(97.7 %id)
CB991506 placenta, pre-eclamptic placenta .b 357 to 996 28 to 667       640/809
(79 %)
14 diff
(98.3 %id)
CB996524 placenta, pre-eclamptic placenta .b 357 to 903 28 to 573       546/677
(80 %)
10 diff
(98.6 %id)
DA060592 cerebellum .b 358 to 608 2 to 256   capped   255/255
(100 %)
4 diff
(98.5 %id)
NM_001533.2   .b 361 to 2474 1 to 2114 exact RefSeq, AAA   2114/2114
(100 %)
0 diff
(100 %id)
DR003347 fetal brain .b 362 to 811 8 to 457       450/457
(98 %)
6 diff
(98.7 %id)
AB044547   .b 366 to 2460 1 to 2092 C396G tiling clone, AAA   2092/2092
(100 %)
9 diff
(99.6 %id)
BI116972 lung, small cell carcinoma .b 373 to 1061 1 to 685       685/685
(100 %)
39 diff
(94.4 %id)
DB109297 thymus .b 373 to 939 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
BF127689 leiomyosarcoma cell line, uterus .b 378 to 996 1 to 619       619/947
(65 %)
23 diff
(97.6 %id)
DA522099 brain .b 389 to 843 2 to 457   capped   456/456
(100 %)
2 diff
(99.6 %id)
TI_57148889   .b 391 to 1028 13 to 658       646/658
(98 %)
11 diff
(98.4 %id)
BG707380 brain, hypothalamus .b 393 to 1182 1 to 790       790/813
(97 %)
20 diff
(97.6 %id)
BI666845 brain, hypothalamus .b 393 to 1215 1 to 830       830/831
(99 %)
22 diff
(97.4 %id)
CB997640 placenta, pre-eclamptic placenta .b 398 to 1080 28 to 710       683/845
(80 %)
10 diff
(98.9 %id)
TI_44343038   .b 398 to 1215 126 to 950       825/951
(86 %)
24 diff
(97.5 %id)
DA159891 amygdala .b 399 to 776 2 to 379   capped   378/378
(100 %)
1 diff
(99.8 %id)
DA535394 heart .b 399 to 984 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA913925   .b 400 to 904 2 to 513   capped   512/512
(100 %)
9 diff
(98.3 %id)
BP202943 coronary artery .b 401 to 968 1 to 569       569/569
(100 %)
6 diff
(99.0 %id)
DB456963 testis .b 401 to 897 1 to 497       497/497
(100 %)
2 diff
(99.6 %id)
DB482557 hippocampus .b 401 to 896 1 to 496       496/496
(100 %)
5 diff
(99.0 %id)
DA585540 lung .b 401 to 756 2 to 357   capped   356/356
(100 %)
0 diff
(100 %id)
CB960517 Human Placenta, placenta .b 401 to 977 28 to 612   AAA   585/878
(66 %)
16 diff
(98.2 %id)
AU310658 neuroblastoma .b 401 to 962 22 to 583       562/562
(100 %)
0 diff
(100 %id)
DA679662   .b 401 to 739 2 to 348   capped   347/347
(100 %)
10 diff
(97.2 %id)
AU125955   .b 401 to 1105 2 to 707   capped   706/708
(99 %)
3 diff
(99.6 %id)
BM785551 stomach .b 401 to 1014 1 to 614       614/614
(100 %)
0 diff
(100 %id)
DB080973 testis .b 401 to 858 2 to 459   capped   458/458
(100 %)
0 diff
(100 %id)
BX416321 neuroblastoma .b 405 to 1230 1 to 827       827/827
(100 %)
5 diff
(99.4 %id)
BM476801 leiomyosarcoma, uterus .b 405 to 1253 1 to 852       852/1083
(78 %)
8 diff
(99.3 %id)
BG758108 B-cells, primary B-cells from tonsils (cell line) .b 407 to 1079 1 to 696       691/795
(86 %)
30 diff
(96.3 %id)
BI261742 lymph, lymphoma, cell line .b 408 to 1059 1 to 649       649/649
(100 %)
31 diff
(95.3 %id)
CN278693 embryonic stem cells, cell lines H1, H7, andH9 .b 411 to 799 7 to 395       389/395
(98 %)
6 diff
(98.5 %id)
BX376071 Neuroblastoma Cot 25-normalized .b 412 to 1324 31 to 943       913/948
(96 %)
10 diff
(99.0 %id)
BX333398 Neuroblastoma Cot 25-normalized .b 412 to 1419 31 to 1023       993/1032
(96 %)
24 diff
(97.7 %id)
BG325025 Kidney, renal cell adenocarcinoma .b 412 to 1083 1 to 682       682/842
(80 %)
28 diff
(96.7 %id)
BI764413 pooled colon, kidney, stomach .b 412 to 1028 1 to 626       626/626
(100 %)
12 diff
(98.1 %id)
BX384189   .b 414 to 1324 1 to 904       904/918
(98 %)
11 diff
(98.9 %id)
CN278706 embryonic stem cells, cell lines H1, H7, andH9 .b 415 to 1031 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
BM454604 embryonal carcinoma, cell line, testis .b 417 to 1042 1 to 626       626/1083
(57 %)
8 diff
(99.3 %id)
DR761888 embryonic stem .b 423 to 1241 1 to 819       819/819
(100 %)
0 diff
(100 %id)
CN278703 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 424 to 1039 1 to 617       617/617
(100 %)
2 diff
(99.7 %id)
BU179100 leiomyosarcoma, uterus .b 424 to 1178 1 to 756   available from MGC,   756/897
(84 %)
10 diff
(98.9 %id)
AK313652 cerebellum .b 426 to 2141 1 to 1716   tiling clone,   1716/1716
(100 %)
1 diff
(100.0 %id)
DA071640 cerebellum .b 427 to 985 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BE885077 leiomyosarcoma, uterus .b 432 to 509 1 to 78       78/78
(100 %)
0 diff
(100 %id)
TI_57197602   .b 435 to 1204 24 to 792       769/797
(96 %)
12 diff
(98.5 %id)
CN278689 embryonic stem cells, cell lines H1, H7, andH9 .b 436 to 957 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
BX353773 Neuroblastoma Cot 25-normalized .b 437 to 1424 1 to 977       977/985
(99 %)
20 diff
(98.0 %id)
BE886245 leiomyosarcoma, uterus .b 437 to 509 1 to 73       73/73
(100 %)
0 diff
(100 %id)
BG419040 Kidney, renal cell adenocarcinoma .b 437 to 1169 1 to 737       737/737
(100 %)
41 diff
(94.5 %id)
X16135   .b 437 to 2474 1 to 2033   tiling clone,   2033/2033
(100 %)
3 diff
(99.9 %id)
AA442191   .b 439 to 915 1 to 465       465/465
(100 %)
44 diff
(90.6 %id)
BE261017 brain, neuroblastoma .b 439 to 975 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
BE783177 eye, retinoblastoma .b 443 to 509 1 to 67       67/67
(100 %)
0 diff
(100 %id)
BI819390 pooled brain, lung, testis .b 443 to 1204 1 to 762       762/767
(99 %)
7 diff
(99.1 %id)
BY795175 eye .b 444 to 1572 1 to 1129       1129/1129
(100 %)
0 diff
(100 %id)
CR989960 T-Lymphocytes .b 444 to 1082 1 to 640       640/641
(99 %)
2 diff
(99.7 %id)
CR993247 T-Lymphocytes .b 444 to 1146 1 to 704       704/708
(99 %)
2 diff
(99.8 %id)
BX424045 neuroblastoma .b 446 to 1324 1 to 876       876/881
(99 %)
5 diff
(99.5 %id)
BX458179 neuroblastoma .b 446 to 1227 1 to 783       783/783
(100 %)
1 diff
(99.9 %id)
AW401571 lymph .b 446 to 950 1 to 504       504/504
(100 %)
8 diff
(98.5 %id)
BX355290 Neuroblastoma Cot 50-normalized .b 447 to 1284 1 to 838       838/838
(100 %)
3 diff
(99.7 %id)
CN278695 embryonic stem cells, cell lines H1, H7, andH9 .b 453 to 600 1 to 148       148/148
(100 %)
0 diff
(100 %id)
TI_154137628   .b 454 to 1083 77 to 709       633/846
(74 %)
13 diff
(98.5 %id)
CN278704 embryonic stem cells, DMSO-treated H9 cellline .b 456 to 705 1 to 250       250/250
(100 %)
0 diff
(100 %id)
CN278694 embryonic stem cells, cell lines H1, H7, andH9 .b 458 to 1023 1 to 567       567/567
(100 %)
3 diff
(99.5 %id)
BE252496 eye, retinoblastoma .b 476 to 1113 1 to 641       641/641
(100 %)
5 diff
(99.3 %id)
BQ051537 blood, natural killer cells, cell line .b 503 to 996 1 to 497       497/1367
(36 %)
26 diff
(98.1 %id)
AW402823 lymph .b 525 to 983 1 to 459       459/459
(100 %)
3 diff
(99.4 %id)
TI_154139309   .b 528 to 1201 77 to 750       674/676
(99 %)
18 diff
(97.4 %id)
CN278708 embryonic stem cells, cell lines H1, H7, andH9 .b 536 to 710 1 to 175       175/175
(100 %)
2 diff
(98.9 %id)
BU854827 ovary, teratocarcinoma, cell line .b 538 to 1414 43 to 925       883/963
(91 %)
21 diff
(97.9 %id)
BU859102 ovary, teratocarcinoma, cell line .b 540 to 1298 1 to 769       769/936
(82 %)
8 diff
(99.2 %id)
BX423036 adult brain, brain .b 557 to 1303 1 to 751       751/751
(100 %)
6 diff
(99.3 %id)
BG680057 skin, squamous cell carcinoma .b 563 to 1363 1 to 807       805/807
(99 %)
15 diff
(98.2 %id)
DB363503   .b 2148 to 2465 316 to 1   tiling clone,   316/316
(100 %)
2 diff
(99.4 %id)
BI256815 cervical carcinoma cell line, cervix .c 1 to 704 4 to 708   tiling clone,   708/709
(99 %)
3 diff
(99.6 %id)
NM_001005335.1   .c 1 to 1877 4 to 1880 exact RefSeq, AAA   1880/1880
(100 %)
0 diff
(100 %id)
AL599134   .c 1 to 238 11 to 248       239/239
(100 %)
0 diff
(100 %id)
DA484172 brain .c 1 to 472 3 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
BJ992341 hepatoblastoma .c 1 to 448 2 to 449       449/449
(100 %)
0 diff
(100 %id)
DB245288 uterus, tumor tissue .c 1 to 446 3 to 448   capped   447/449
(99 %)
1 diff
(99.8 %id)
BI915021 brain .c 12 to 760 1 to 750       750/751
(99 %)
8 diff
(99.0 %id)
BF314604 brain, neuroblastoma .c 31 to 651 136 to 753       748/955
(78 %)
36 diff
(96.3 %id)
BQ880051 dorsal root ganglia .c 39 to 656 138 to 756       621/1059
(58 %)
11 diff
(99.0 %id)
BF762371 colon_est .c 41 to 399 362 to 4     Submitted on the opposite strand 359/378
(94 %)
4 diff
(99.0 %id)
BQ308259 breast .c 41 to 580 20 to 554       537/554
(96 %)
7 diff
(98.8 %id)
BE391512 endometrium, adenocarcinoma cell line, uterus .c 41 to 511 27 to 497       473/497
(95 %)
6 diff
(98.8 %id)
BE390077 endometrium, adenocarcinoma cell line, uterus .c 41 to 704 34 to 693       661/718
(92 %)
13 diff
(98.2 %id)
BI772421 pooled lung and spleen .c 41 to 471 10 to 438       430/438
(98 %)
6 diff
(98.7 %id)
TI_57179994   .c 41 to 471 45 to 473       430/473
(90 %)
6 diff
(98.8 %id)
TI_57239033   .c 41 to 760 63 to 782       720/783
(91 %)
11 diff
(98.6 %id)
BF763534 colon_est .c 42 to 399 19 to 378       360/384
(93 %)
8 diff
(98.0 %id)
BQ055025 lymph, lymphoma, cell line .c 43 to 824 1 to 784       784/1061
(73 %)
11 diff
(99.0 %id)
AW401391 lymph .c 45 to 645 1 to 601       601/601
(100 %)
3 diff
(99.6 %id)
BI523525 brain .c 45 to 776 1 to 733       733/738
(99 %)
11 diff
(98.6 %id)
TI_44185025   .c 45 to 776 1 to 733       733/738
(99 %)
11 diff
(98.6 %id)
AA314609 colon .c 48 to 506 1 to 459       459/459
(100 %)
0 diff
(100 %id)
AA322841 brain, cerebellum .c 50 to 284 1 to 235       235/235
(100 %)
1 diff
(99.6 %id)
TI_154137506   .c 51 to 753 79 to 783       705/860
(81 %)
6 diff
(99.4 %id)
CV569475 cornea, eye .c 58 to 665 1 to 608       608/608
(100 %)
0 diff
(100 %id)
BX425045 placenta .c 59 to 626 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BE793085 lung, small cell carcinoma .c 74 to 824 1 to 750       750/753
(99 %)
23 diff
(97.0 %id)
BE792697 lung, small cell carcinoma .c 74 to 767 1 to 691       691/691
(100 %)
3 diff
(99.6 %id)
W20114 lung .c 148 to 439 1 to 300       300/300
(100 %)
7 diff
(97.7 %id)
CF145048 CNCAP(3)T-225 cell line, Prostate .c 205 to 483 1 to 279       279/280
(99 %)
10 diff
(96.5 %id)
CF123355 CNCAP(3)T-225 cell line, Prostate .c 205 to 581 1 to 379       379/379
(100 %)
12 diff
(96.9 %id)
BE620972 epithelioid carcinoma, Pancreas .c 208 to 840 1 to 629       629/634
(99 %)
8 diff
(98.8 %id)
BE909768 epithelioid carcinoma, Pancreas .c 208 to 799 1 to 592       592/600
(98 %)
4 diff
(99.4 %id)
AW390041 stomach .c 241 to 512 275 to 1       275/275
(100 %)
8 diff
(97.1 %id)
AW390048 stomach .c 241 to 516 277 to 1       277/277
(100 %)
1 diff
(99.7 %id)
DA628717 Kidney .c 241 to 779 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
AA434170 ovarian tumor, ovary .c 249 to 656 1 to 409     Submitted on the opposite strand 409/409
(100 %)
5 diff
(98.8 %id)
AI693946 pooled .c 262 to 891 694 to 66       629/694
(90 %)
38 diff
(94.6 %id)
BP256613 Kidney .c 312 to 880 1 to 568       568/579
(98 %)
4 diff
(99.4 %id)
AA355934   .c 326 to 606 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
CA454628   .c 329 to 1185 1 to 869       867/874
(99 %)
19 diff
(97.9 %id)
BF095371 uterus_tumor .c 386 to 640 258 to 4       255/278
(91 %)
3 diff
(99.0 %id)
AW513349 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 398 to 699 8 to 309     Submitted on the opposite strand 302/309
(97 %)
6 diff
(98.1 %id)
BP233062 muscle .c 401 to 980 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BU856677 adenocarcinoma, cell line, breast .c 423 to 1131 1 to 712       712/979
(72 %)
9 diff
(99.1 %id)
BM740455 stomach .c 432 to 845 1 to 413       413/413
(100 %)
2 diff
(99.6 %id)
CN278690 embryonic stem cells, cell lines H1, H7, andH9 .c 464 to 873 1 to 410       410/410
(100 %)
0 diff
(100 %id)
BM048702 carcinoma, cell line, Prostate .c 487 to 873 7 to 392       386/441
(87 %)
5 diff
(98.9 %id)
EC511975 Prostate .c 495 to 579 91 to 8       84/91
(92 %)
0 diff
(100 %id)
EC568534 Prostate .c 495 to 586 92 to 1       92/92
(100 %)
0 diff
(100 %id)
CF146783 CNCAP(3)T-225 cell line, Prostate .c 495 to 1236 8 to 748       741/750
(98 %)
8 diff
(99.0 %id)
TI_154179308   .c 495 to 1328 68 to 890       823/824
(99 %)
13 diff
(98.5 %id)
BM424286 amelanotic melanoma, cell line, skin .c 511 to 1308 1 to 803       803/1031
(77 %)
16 diff
(98.5 %id)
CA407601 adipose .c 515 to 845 1 to 331       331/332
(99 %)
3 diff
(99.1 %id)
AA308252 colon .c 527 to 853 1 to 327       327/327
(100 %)
0 diff
(100 %id)
BF855769 prostate_normal .c 530 to 786 280 to 23     Submitted on the opposite strand 258/282
(91 %)
0 diff
(100 %id)
CF122252 CNCAP(3)T-225 cell line, Prostate .c 534 to 1234 1 to 700       700/700
(100 %)
7 diff
(99.0 %id)
CF122828 CNCAP(3)T-225 cell line, Prostate .c 534 to 1170 1 to 638       638/638
(100 %)
6 diff
(99.1 %id)
BF569716 Kidney, renal carcinoma (ascites) .c 541 to 871 1 to 330       330/987
(33 %)
2 diff
(99.8 %id)
TI_154181766   .c 541 to 1455 70 to 975       906/907
(99 %)
14 diff
(98.5 %id)
TI_154182537   .c 541 to 1328 69 to 857       789/797
(98 %)
10 diff
(98.8 %id)
BG740534 skin .c 542 to 829 1 to 288       288/288
(100 %)
0 diff
(100 %id)
CF123361 CNCAP(3)T-225 cell line, Prostate .c 543 to 1256 1 to 715       715/718
(99 %)
8 diff
(98.9 %id)
CB163409 Liver .c 544 to 1022 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
BX410247 adult brain, brain .c 545 to 1454 1 to 906       907/906
(100 %)
21 diff
(97.7 %id)
TI_154183298   .c 549 to 1290 68 to 807       740/821
(90 %)
6 diff
(99.3 %id)
CF134696 CNCAP(3)T-225 cell line, Prostate .c 555 to 1129 8 to 582       575/587
(97 %)
14 diff
(97.7 %id)
TI_154162729   .c 555 to 1336 79 to 865       787/1170
(67 %)
25 diff
(97.9 %id)
BM811393 amelanotic melanoma, cell line, skin .c 556 to 1300 32 to 789       758/1055
(71 %)
28 diff
(97.4 %id)
BM558400 amelanotic melanoma, cell line, skin .c 556 to 1328 1 to 775       775/1069
(72 %)
8 diff
(99.3 %id)
BG743915 blood, natural killer cells, cell line .c 568 to 871 1 to 304       304/338
(89 %)
5 diff
(98.6 %id)
BM564115 blood, natural killer cells, cell line .c 570 to 1286 1 to 731       731/1340
(54 %)
7 diff
(99.5 %id)
CB129564 Liver .c 574 to 874 1 to 301       301/301
(100 %)
2 diff
(99.4 %id)
CF141490 CNCAP(3)T-225 cell line, Prostate .c 575 to 1069 8 to 502       495/502
(98 %)
0 diff
(100 %id)
TI_154172263   .c 575 to 1188 80 to 693       614/614
(100 %)
6 diff
(99.1 %id)
CX871991 embryonic stem .c 576 to 1113 1 to 539       539/539
(100 %)
5 diff
(99.1 %id)
CA487390   .c 580 to 1394 42 to 861   tiling clone,   822/917
(89 %)
18 diff
(98.1 %id)
H30784 brain .c 613 to 1093 1 to 487       487/487
(100 %)
20 diff
(95.9 %id)
AA357097   .c 632 to 871 1 to 240       240/240
(100 %)
0 diff
(100 %id)
F00223 leg muscle, skeletal muscle .c 645 to 852 208 to 1       208/247
(84 %)
1 diff
(99.6 %id)
CN278698 embryonic stem cells, cell lines H1, H7, andH9 .c 645 to 1321 1 to 678       678/678
(100 %)
3 diff
(99.6 %id)
CF134794 CNCAP(3)T-225 cell line, Prostate .c 655 to 1134 1 to 480       480/480
(100 %)
7 diff
(98.6 %id)
CA488455   .c 682 to 1655 1 to 976       976/976
(100 %)
16 diff
(98.4 %id)
CD611918   .c 718 to 868 1 to 151       151/152
(99 %)
2 diff
(98.7 %id)
CN278696 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 724 to 1483 1 to 762       762/765
(99 %)
8 diff
(99.0 %id)
BM761257 myeloma .c 752 to 1213 1 to 462       462/462
(100 %)
0 diff
(100 %id)
BM846676 myeloma .c 752 to 1039 1 to 289       289/289
(100 %)
2 diff
(99.4 %id)
R88490 brain .c 774 to 1228 1 to 467       467/470
(99 %)
15 diff
(96.9 %id)
R88498 brain .c 775 to 1121 1 to 347       347/347
(100 %)
1 diff
(99.8 %id)
R89642 brain .c 775 to 1251 1 to 495       495/501
(98 %)
21 diff
(95.9 %id)
CD611919   .c 780 to 1453 667 to 1       667/667
(100 %)
14 diff
(98.0 %id)
CN278702 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 805 to 1410 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
R85314 brain .c 819 to 984 1 to 166       166/166
(100 %)
3 diff
(98.2 %id)
DR422204 eye, Pterygium .c 852 to 1417 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BU163712 epidermoid carcinoma, cell line, salivary gland .c 862 to 1480 1 to 622       622/1009
(61 %)
11 diff
(99.0 %id)
CD671939 eye, Iris .c 863 to 1272 1 to 408       408/408
(100 %)
3 diff
(99.3 %id)
AI440387 B-cell, chronic lymphotic leukemia .c 873 to 1011 146 to 8       139/146
(95 %)
0 diff
(100 %id)
AW517105 cervix .c 873 to 999 131 to 5       127/131
(96 %)
0 diff
(100 %id)
CN278705 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 882 to 1479 1 to 599       599/599
(100 %)
6 diff
(99.0 %id)
BE709598 head_neck .c 886 to 1238 1 to 353       353/358
(98 %)
5 diff
(98.7 %id)
CA454489   .c 892 to 1728 1 to 847       847/931
(90 %)
18 diff
(98.1 %id)
T19454   .c 900 to 1230 1 to 331       331/333
(99 %)
3 diff
(99.1 %id)
BX353754 Neuroblastoma Cot 25-normalized .c 901 to 1806 9 to 908   AAA   900/960
(93 %)
15 diff
(98.5 %id)
BE910593 epithelioid carcinoma, Pancreas .c 924 to 1660 1 to 726       726/932
(77 %)
26 diff
(97.3 %id)
AW889888 nervous_tumor .c 930 to 1250 1 to 321       321/321
(100 %)
4 diff
(98.8 %id)
BF084286 colon .c 950 to 1320 1 to 373       373/373
(100 %)
9 diff
(97.6 %id)
T28977 blood, white blood cells .c 956 to 1329 1 to 376       376/386
(97 %)
4 diff
(99.0 %id)
TI_57164307   .c 963 to 1606 66 to 709       644/934
(68 %)
7 diff
(99.3 %id)
TI_57164383   .c 963 to 1739 57 to 842       786/859
(91 %)
35 diff
(96.0 %id)
BI833910 pooled pancreas and spleen .c 966 to 1739 1 to 783       783/800
(97 %)
29 diff
(96.4 %id)
BI833983 pooled pancreas and spleen .c 966 to 1606 1 to 641       641/866
(74 %)
1 diff
(99.9 %id)
BX282757 pooled pancreas and spleen .c 971 to 1481 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BF378557 uterus .c 997 to 1231 243 to 10       234/244
(95 %)
0 diff
(100 %id)
AW949411   .c 1004 to 1635 1 to 632       632/632
(100 %)
0 diff
(100 %id)
AW949412   .c 1004 to 1498 1 to 496       496/496
(100 %)
11 diff
(97.8 %id)
TI_149297901   .c 1008 to 1874 949 to 96   AAA   856/941
(90 %)
23 diff
(97.6 %id)
BE884014 leiomyosarcoma, uterus .c 1013 to 1640 1 to 624       624/625
(99 %)
5 diff
(99.2 %id)
CN278699 embryonic stem cells, DMSO-treated H9 cellline .c 1019 to 1630 1 to 612       612/612
(100 %)
0 diff
(100 %id)
TI_149294566   .c 1029 to 1868 916 to 96   AAA   821/938
(87 %)
22 diff
(97.7 %id)
BM906442 ovary (pool of 3) .c 1041 to 1863 3 to 826   tiling clone,   824/1090
(75 %)
18 diff
(98.4 %id)
CN278700 embryonic stem cells, DMSO-treated H9 cellline .c 1042 to 1510 1 to 469       469/469
(100 %)
0 diff
(100 %id)
CN278691 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1054 to 1710 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
BG339177 leiomyosarcoma cell line, uterus .c 1083 to 1644 1 to 563       563/872
(64 %)
8 diff
(99.1 %id)
BM313511 Pancreas, Purified pancreatic islet .c 1084 to 1576 1 to 493       493/493
(100 %)
5 diff
(99.0 %id)
BI001525 head_normal .c 1092 to 1598 1 to 507       507/507
(100 %)
5 diff
(99.1 %id)
BF699118 brain, primitive neuroectoderm .c 1095 to 1649 1 to 552       552/862
(64 %)
8 diff
(99.1 %id)
BF115574 brain, glioblastoma (pooled) .c 1107 to 1539 433 to 1       433/433
(100 %)
5 diff
(98.9 %id)
BG949590 breast .c 1131 to 1546 1 to 413       413/413
(100 %)
8 diff
(98.1 %id)
BX453912 placenta .c 1134 to 1809 745 to 62       684/888
(77 %)
26 diff
(97.1 %id)
BF001823 colon, colon tumor, RER+ .c 1140 to 1874 725 to 1       725/725
(100 %)
21 diff
(97.2 %id)
BG254679 adenocarcinoma, cell line, Prostate .c 1156 to 1738 1 to 582       582/777
(74 %)
27 diff
(96.6 %id)
AI560852 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1170 to 1868 718 to 30   AAA   689/690
(99 %)
48 diff
(93.1 %id)
BM454585 embryonal carcinoma, cell line, testis .c 1173 to 1863 1 to 686       686/1029
(66 %)
13 diff
(98.8 %id)
DN914215   .c 1182 to 1501 320 to 1       320/320
(100 %)
0 diff
(100 %id)
BF939915 brain, glioblastoma (pooled) .c 1197 to 1863 666 to 1       666/670
(99 %)
26 diff
(96.2 %id)
TI_149292780   .c 1199 to 1877 782 to 108   AAA   675/676
(99 %)
8 diff
(98.9 %id)
AI568436 anaplastic oligodendroglioma, brain .c 1204 to 1877 661 to 1       661/661
(100 %)
17 diff
(97.5 %id)
TI_149301050   .c 1204 to 1874 752 to 85   AAA   668/668
(100 %)
9 diff
(98.7 %id)
DN914214   .c 1214 to 1501 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
CB850892 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1225 to 1874 663 to 17   AAA   647/647
(100 %)
9 diff
(98.7 %id)
BE768903 prostate_tumor .c 1236 to 1566 331 to 1       331/331
(100 %)
4 diff
(98.8 %id)
BM313346 Pancreas, Purified pancreatic islet .c 1245 to 1873 628 to 1       628/628
(100 %)
12 diff
(98.1 %id)
BF818659 colon_ins .c 1246 to 1592 1 to 347       347/347
(100 %)
1 diff
(99.8 %id)
BE716946 head_neck .c 1250 to 1605 359 to 1       359/362
(99 %)
8 diff
(97.8 %id)
BE716962 head_neck .c 1250 to 1603 363 to 9       355/366
(96 %)
5 diff
(98.7 %id)
BE840755 prostate_normal .c 1250 to 1607 359 to 1       359/362
(99 %)
8 diff
(97.8 %id)
BE770807 prostate_tumor .c 1252 to 1608 10 to 367       358/371
(96 %)
14 diff
(96.3 %id)
BE840756 prostate_normal .c 1252 to 1608 9 to 366       358/369
(97 %)
14 diff
(96.3 %id)
BE770804 prostate_tumor .c 1258 to 1608 8 to 360       353/364
(96 %)
10 diff
(97.3 %id)
BE770808 prostate_tumor .c 1263 to 1608 1 to 347       347/351
(98 %)
5 diff
(98.6 %id)
BE840735 prostate_normal .c 1263 to 1608 28 to 375       346/376
(92 %)
9 diff
(97.7 %id)
AW362334 colon .c 1264 to 1621 1 to 358       358/358
(100 %)
13 diff
(96.4 %id)
BE716932 head_neck .c 1298 to 1595 299 to 3       297/299
(99 %)
0 diff
(100 %id)
BE716924 head_neck .c 1307 to 1587 288 to 3       286/288
(99 %)
1 diff
(99.7 %id)
BE716997 head_neck .c 1307 to 1608 1 to 303       303/307
(98 %)
5 diff
(98.4 %id)
AW796530 uterus .c 1311 to 1542 1 to 232       232/240
(96 %)
2 diff
(99.2 %id)
BU941150 mixed (pool of 40 RNAs) .c 1311 to 1888 1 to 572       572/846
(67 %)
9 diff
(99.0 %id)
AI538287 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1323 to 1868 565 to 24   AAA   542/592
(91 %)
15 diff
(97.5 %id)
R91029 liver and spleen .c 1324 to 1656 1 to 333       333/333
(100 %)
2 diff
(99.4 %id)
TI_154135906   .c 1324 to 1877 666 to 114   AAA   553/631
(87 %)
10 diff
(98.5 %id)
AI688539 colon .c 1325 to 1868 551 to 14   AAA   538/575
(93 %)
13 diff
(97.8 %id)
AW027632 thymus, pooled .c 1326 to 1875 552 to 6       547/555
(98 %)
7 diff
(98.8 %id)
AW512655 lymph node, lymphoma, follicular mixed small and largecell .c 1326 to 1871 546 to 4       543/561
(96 %)
16 diff
(97.2 %id)
BE540017 cervix .c 1334 to 1881 1 to 539       539/573
(94 %)
9 diff
(98.5 %id)
CA311125 Human Lung Epithelial cells, lung .c 1335 to 1868 544 to 14   AAA   531/533
(99 %)
14 diff
(97.4 %id)
BM977689 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1336 to 1877 557 to 19   AAA   539/539
(100 %)
34 diff
(93.7 %id)
CA429943 Cell Line, Chondrosarcoma .c 1336 to 1868 546 to 14   AAA   533/533
(100 %)
7 diff
(98.7 %id)
CA431119 cell lines, Chondrosarcoma .c 1336 to 1868 544 to 14   AAA   531/531
(100 %)
13 diff
(97.6 %id)
BQ223918 embryonal carcinoma, cell line, testis .c 1345 to 1886 1 to 537       537/576
(93 %)
4 diff
(99.4 %id)
AI970557 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1347 to 1863 532 to 17   AAA   516/516
(100 %)
18 diff
(96.6 %id)
BQ772476 Chondrosarcoma Cell line .c 1380 to 1877 515 to 19   AAA   497/499
(99 %)
16 diff
(96.8 %id)
BM974752 lung .c 1381 to 1877 512 to 19   AAA   494/494
(100 %)
6 diff
(98.8 %id)
BM985093 lung .c 1381 to 1868 501 to 14   AAA   488/488
(100 %)
3 diff
(99.4 %id)
BM982898 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1381 to 1874 509 to 17   AAA   493/493
(100 %)
5 diff
(99.0 %id)
BE939459 uterus .c 1390 to 1644 8 to 262       255/262
(97 %)
10 diff
(96.2 %id)
AA233867.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1391 to 1864 470 to 1     also hits gene LOC644390 470/470
(100 %)
11 diff
(97.7 %id)
BG206760   .c 1392 to 1549 1 to 158       158/158
(100 %)
6 diff
(96.3 %id)
AI288381 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1393 to 1868 492 to 23   AAA   470/484
(97 %)
8 diff
(98.4 %id)
BU615961 Bone, Subchondral Bone .c 1395 to 1868 490 to 19   AAA   472/472
(100 %)
7 diff
(98.6 %id)
AI128883 anaplastic oligodendroglioma, brain .c 1401 to 1863 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
BM821092 stomach .c 1402 to 1524 1 to 123       123/123
(100 %)
0 diff
(100 %id)
BM997815 lung, Lung Focal Fibrosis .c 1417 to 1877 480 to 16   AAA   465/465
(100 %)
5 diff
(99.0 %id)
CA431611 cell lines, Enchondroma .c 1419 to 1877 476 to 19   AAA   458/458
(100 %)
7 diff
(98.5 %id)
BJ992342 hepatoblastoma .c 1505 to 1842 340 to 1       340/340
(100 %)
3 diff
(99.2 %id)
BQ422051 embryonal carcinoma, cell line, testis .c 1523 to 1869 1 to 340       340/934
(36 %)
3 diff
(99.7 %id)
AI926936 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1526 to 1868 358 to 22   AAA   337/337
(100 %)
9 diff
(97.4 %id)
AA631646 germ cell tumor .c 1537 to 1875 338 to 1       338/338
(100 %)
2 diff
(99.5 %id)
BX327635 Neuroblastoma Cot 25-normalized .c 1539 to 1871 1 to 330       330/333
(99 %)
9 diff
(97.3 %id)
N90702 lung .c 1552 to 1868 317 to 1       317/319
(99 %)
0 diff
(100 %id)
CA428960 Cell Line, Chondrosarcoma .c 1563 to 1877 333 to 19   tiling clone, AAA   315/315
(100 %)
1 diff
(99.7 %id)
CB986142 Pooled-Glandular .c 1568 to 1866 1 to 297       297/304
(97 %)
3 diff
(99.1 %id)
AI432801 lymph node, lymphoma, follicular mixed small and largecell .c 1572 to 1868 319 to 26   AAA   294/294
(100 %)
4 diff
(98.7 %id)
D29536   .c 1576 to 1863 1 to 291       291/291
(100 %)
14 diff
(95.2 %id)
AA531540 invasive prostate tumor, Prostate .c 1590 to 1868 1 to 272   AAA   272/272
(100 %)
4 diff
(98.6 %id)
AA535418 invasive prostate tumor, Prostate .c 1590 to 1850 1 to 254       254/254
(100 %)
3 diff
(98.9 %id)
AA937108 germinal center B cell .c 1613 to 1844 1 to 230     Submitted on the opposite strand 230/230
(100 %)
3 diff
(98.7 %id)
BM968861 lung, Primary Lung Epithelial Cells .c 1634 to 1877 265 to 19   AAA   247/272
(90 %)
6 diff
(97.8 %id)
AW074570 colon, moderately differentiated adenocarcinoma .c 1641 to 1877 262 to 28   AAA   235/235
(100 %)
5 diff
(97.9 %id)
CB241592 Human Lung Epithelial cells, lung .c 1649 to 1874 244 to 19   AAA   226/261
(86 %)
1 diff
(99.7 %id)
AW080402 esophagus, squamous cell carcinoma .c 1656 to 1863 1 to 208   AAA Submitted on the opposite strand 208/208
(100 %)
0 diff
(100 %id)
AI291829 placenta .c 1665 to 1739 1 to 75     Submitted on the opposite strand 75/75
(100 %)
1 diff
(98.7 %id)
BU198038 ectopic and normal uterine endometrium .c 1669 to 1872 236 to 33   AAA   204/211
(96 %)
0 diff
(100 %id)
AA514835 breast .c 1669 to 1865 197 to 1       197/197
(100 %)
0 diff
(100 %id)
R88770 liver and spleen .c 1675 to 1875 201 to 1       201/201
(100 %)
10 diff
(95.1 %id)
AW022409 cochlea, ear .c 1714 to 1871 1 to 157       157/171
(91 %)
6 diff
(96.5 %id)
AW938842 denis_drash .c 1725 to 1831 105 to 1     Submitted on the opposite strand 105/105
(100 %)
5 diff
(95.3 %id)
BM354180 Islets of Langerhans, Pancreas .c 1728 to 1888 1 to 161   tiling clone,   161/189
(85 %)
1 diff
(99.5 %id)
BM263222 Islets of Langerhans, Pancreas .c 1731 to 1888 1 to 158       158/190
(83 %)
1 diff
(99.5 %id)
BI496535 cochlea, ear .c 1734 to 1862 142 to 14   AAA   129/133
(96 %)
2 diff
(98.5 %id)
AA283192 ovarian tumor, ovary .c 1744 to 1878 136 to 2       135/136
(99 %)
0 diff
(100 %id)
AA485382 ovarian tumor, ovary .c 1744 to 1878 136 to 2       135/136
(99 %)
0 diff
(100 %id)
EC534577 Prostate .c 1749 to 1871 122 to 2       121/122
(99 %)
0 diff
(100 %id)
EC558228 Prostate .c 1749 to 1871 122 to 1       122/122
(100 %)
1 diff
(99.2 %id)
EC563824 Prostate .c 1749 to 1871 120 to 2       119/120
(99 %)
0 diff
(100 %id)
EC535608 Prostate .c 1751 to 1874 122 to 1       122/122
(100 %)
4 diff
(96.8 %id)
EC548931 Prostate .c 1751 to 1874 118 to 1       118/118
(100 %)
4 diff
(96.7 %id)
EC531371 Prostate .c 1752 to 1871 120 to 1       120/120
(100 %)
2 diff
(98.4 %id)
CN277724 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1757 to 1887 1 to 130   AAA   130/130
(100 %)
1 diff
(99.3 %id)
AA205113   .c 1758 to 1863 109 to 4       106/109
(97 %)
0 diff
(100 %id)
CB108523 Liver .c 1791 to 1868 1 to 78   AAA   78/78
(100 %)
0 diff
(100 %id)
BP368293 thymus .d 1 to 579 2 to 580   tiling clone,   580/580
(100 %)
0 diff
(100 %id)
CB120749 Liver .d 26 to 618 1 to 593   tiling clone,   593/593
(100 %)
0 diff
(100 %id)
CX762837 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 598 to 1312 1 to 715   tiling clone, Submitted on the opposite strand 715/715
(100 %)
0 diff
(100 %id)
CD389158 embryonic trophoblasts, made from WA01 stemcells .e 1 to 859 21 to 884   tiling clone,   862/884
(97 %)
19 diff
(97.9 %id)
NM_001398.2   .e 14 to 1270 1 to 1257 exact RefSeq, AAA   1257/1257
(100 %)
0 diff
(100 %id)
BQ216018 embryonal carcinoma, cell line, testis .e 26 to 741 1 to 723       723/864
(83 %)
10 diff
(98.9 %id)
BU558131 adenocarcinoma, cell line, breast .e 32 to 909 23 to 903       881/934
(94 %)
26 diff
(97.3 %id)
CD107695 brain, Pituitary .e 33 to 835 1 to 807       807/868
(92 %)
12 diff
(98.7 %id)
U16660 retina .e 72 to 1268 1 to 1196 Q210E R230H G239D A259P A262P ...     1196/1196
(100 %)
14 diff
(98.9 %id)
BI830864 brain, medulla .e 73 to 878 1 to 808       808/808
(100 %)
6 diff
(99.3 %id)
TI_57177358   .e 73 to 950 69 to 948       880/949
(92 %)
15 diff
(98.5 %id)
BF967397 brain, hypothalamus .e 74 to 715 1 to 642   fully sequenced,   640/640
(100 %)
9 diff
(98.6 %id)
BC017408 Skin, melanotic melanoma, high MDR. .e 77 to 1270 5 to 1198 E41A tiling clone, available from MGC, AAA   1194/1194
(100 %)
1 diff
(100.0 %id)
BM907205 large cell carcinoma, lung .e 77 to 949 1 to 879       877/984
(89 %)
24 diff
(97.6 %id)
BP340659 Spleen .e 77 to 656 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP870554 embryonal kidney .e 79 to 410 1 to 332       332/332
(100 %)
0 diff
(100 %id)
AK291860 skeletal muscle .e 79 to 1274 1 to 1196 E41A     1196/1196
(100 %)
1 diff
(100.0 %id)
BP209341 cerebellum .e 79 to 655 1 to 577       577/577
(100 %)
0 diff
(100 %id)
DB492425 hypothalamus .e 79 to 547 1 to 469       469/469
(100 %)
0 diff
(100 %id)
CB147811 Liver .e 79 to 617 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BP320787 placenta .e 79 to 673 1 to 595       595/595
(100 %)
0 diff
(100 %id)
CB145556 Liver .e 80 to 627 1 to 548       548/548
(100 %)
0 diff
(100 %id)
DA892819 skeletal muscle .e 80 to 819 2 to 738   fully sequenced, capped   737/737
(100 %)
14 diff
(98.2 %id)
DA894528 skeletal muscle .e 80 to 625 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BP352139   .e 80 to 660 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA089431 cerebellum .e 81 to 649 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BP249383 Kidney .e 81 to 663 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP321264 placenta .e 82 to 664 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA828987 placenta .e 83 to 687 2 to 607   capped   606/787
(77 %)
3 diff
(99.7 %id)
DA896356 skeletal muscle .e 83 to 640 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
TI_57165010   .e 85 to 904 39 to 856       818/857
(95 %)
12 diff
(98.6 %id)
TI_59382962   .e 85 to 835 59 to 811       751/760
(98 %)
10 diff
(98.7 %id)
BG546912 lung .e 86 to 903 1 to 824       762/824
(92 %)
17 diff
(98.0 %id)
BQ232040 embryonal carcinoma, cell line, testis .e 86 to 835 1 to 754       754/971
(77 %)
13 diff
(98.7 %id)
CF127702 Chondrosarcoma Lung Metastasis cell lines, lung .e 86 to 804 1 to 719       719/719
(100 %)
0 diff
(100 %id)
BP315620 mammary gland .e 86 to 667 1 to 582       582/582
(100 %)
0 diff
(100 %id)
TI_154193270   .e 86 to 961 51 to 920       870/873
(99 %)
13 diff
(98.6 %id)
DA083886 cerebellum .e 87 to 655 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BG677698 skin, squamous cell carcinoma .e 88 to 949 1 to 863       863/863
(100 %)
8 diff
(99.1 %id)
BM472914 duodenal adenocarcinoma, cell line, small intestine .e 88 to 976 1 to 895       895/1004
(89 %)
22 diff
(97.9 %id)
BY798786 eye .e 89 to 709 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BM547081 brain, hippocampus .e 89 to 981 15 to 912       898/1068
(84 %)
26 diff
(97.6 %id)
TI_57145857   .e 89 to 1038 62 to 1016       955/1017
(93 %)
26 diff
(97.5 %id)
CN313088 embryonic stem cells, DMSO-treated H9 cellline .e 90 to 356 1 to 267       267/267
(100 %)
0 diff
(100 %id)
CR620644 Neuroblastoma Cot 50-normalized .e 90 to 1253 1 to 1164 exact     1164/1164
(100 %)
0 diff
(100 %id)
BG697417 skin .e 90 to 945 1 to 856       856/862
(99 %)
9 diff
(99.0 %id)
BI223615 cervical carcinoma cell line, cervix .e 90 to 964 1 to 866       866/946
(91 %)
9 diff
(99.1 %id)
TI_57215760   .e 90 to 924 35 to 874       840/874
(96 %)
25 diff
(97.2 %id)
CR600133 Neuroblastoma Cot 25-normalized .e 91 to 1263 1 to 1173 exact     1173/1173
(100 %)
0 diff
(100 %id)
BX353730 Neuroblastoma Cot 25-normalized .e 91 to 478 1 to 388   fully sequenced,   388/388
(100 %)
1 diff
(99.8 %id)
BQ054346 blood, natural killer cells, cell line .e 91 to 1117 1 to 1037 G207X R230P K231Q K250X A259X ...     1037/1053
(98 %)
36 diff
(96.6 %id)
BU177185 melanotic melanoma, skin .e 91 to 885 1 to 803       801/835
(95 %)
11 diff
(98.7 %id)
BQ224419 epithelioid carcinoma, Pancreas .e 92 to 946 1 to 859       859/860
(99 %)
12 diff
(98.7 %id)
TI_57202987   .e 92 to 1011 59 to 985       927/985
(94 %)
26 diff
(97.4 %id)
TI_57237109   .e 92 to 952 97 to 962       866/962
(90 %)
24 diff
(97.6 %id)
BU185929 ductal carcinoma, cell line, Pancreas .e 93 to 945 1 to 858       858/884
(97 %)
21 diff
(97.7 %id)
BU195930 melanotic melanoma, cell line, skin .e 93 to 927 1 to 844       844/910
(92 %)
24 diff
(97.4 %id)
BQ689700 ductal carcinoma, cell line, Pancreas .e 93 to 964 1 to 871       871/877
(99 %)
11 diff
(98.8 %id)
BQ642839 lymph, lymphoma, cell line .e 93 to 995 1 to 913       913/916
(99 %)
11 diff
(98.8 %id)
BI335179 cervical carcinoma cell line, cervix .e 94 to 988 1 to 894       894/917
(97 %)
21 diff
(97.8 %id)
BI758962 pooled colon, kidney, stomach .e 94 to 1038 1 to 950       950/951
(99 %)
20 diff
(97.9 %id)
BI768354 pooled lung and spleen .e 94 to 881 1 to 786       786/786
(100 %)
4 diff
(99.5 %id)
BU168450 ductal carcinoma, cell line, Pancreas .e 94 to 1107 1 to 1020 V270R A271G V272G Q273A S274X ...     1020/1025
(99 %)
20 diff
(98.1 %id)
BM918429 pooled pancreas and spleen .e 95 to 1117 1 to 1031 V270R A271G V272G Q273A S274E ...     1031/1080
(95 %)
27 diff
(97.5 %id)
CR603672 Neuroblastoma Cot 50-normalized .e 96 to 1253 1 to 1158 exact     1158/1158
(100 %)
0 diff
(100 %id)
CR620208 Neuroblastoma Cot 10-normalized .e 96 to 1123 1 to 1028 exact     1028/1028
(100 %)
0 diff
(100 %id)
AL522702 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 96 to 478 1 to 383   fully sequenced,   383/383
(100 %)
1 diff
(99.8 %id)
BI819748 pooled brain, lung, testis .e 96 to 1011 1 to 923       923/923
(100 %)
21 diff
(97.8 %id)
BI911075 leukocyte .e 96 to 952 1 to 862       862/862
(100 %)
18 diff
(98.0 %id)
AA313933 colon .e 97 to 609 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BC011792 Pancreas, epithelioid carcinoma .e 97 to 1270 1 to 1174 exact available from MGC, AAA   1174/1174
(100 %)
1 diff
(100.0 %id)
BG675745 skin, squamous cell carcinoma .e 97 to 948 1 to 852       852/852
(100 %)
22 diff
(97.5 %id)
BQ674369 epidermoid carcinoma, cell line, salivary gland .e 97 to 1027 11 to 942       932/943
(98 %)
16 diff
(98.4 %id)
BQ231416 embryonal carcinoma, cell line, testis .e 98 to 912 1 to 818       818/864
(94 %)
14 diff
(98.4 %id)
BQ424824 eye, retinoblastoma .e 98 to 915 1 to 825       825/913
(90 %)
6 diff
(99.4 %id)
CN313092 embryonic stem cells, DMSO-treated H9 cellline .e 99 to 410 1 to 312       312/312
(100 %)
0 diff
(100 %id)
BQ925484 large cell carcinoma, lung .e 99 to 981 1 to 895       893/934
(95 %)
53 diff
(94.4 %id)
CD611418   .e 100 to 663 1 to 564       564/564
(100 %)
0 diff
(100 %id)
CD611419   .e 100 to 881 1 to 785       785/785
(100 %)
9 diff
(98.9 %id)
CD611425   .e 100 to 683 1 to 584       584/584
(100 %)
0 diff
(100 %id)
CD611428   .e 100 to 688 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BQ420641 epithelioid carcinoma, Pancreas .e 100 to 977 1 to 882       882/882
(100 %)
21 diff
(97.7 %id)
CB159190 Liver .e 100 to 677 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BI861283 breast, mammary adenocarcinoma, cell line .e 101 to 950 1 to 853       853/854
(99 %)
13 diff
(98.5 %id)
BQ065006 lymph, lymphoma, cell line .e 101 to 981 1 to 883       883/976
(90 %)
17 diff
(98.3 %id)
BU500103   .e 101 to 1008 1 to 911       911/911
(100 %)
14 diff
(98.5 %id)
BU148553 carcinoma, cell line, Prostate .e 101 to 981 20 to 906       887/935
(94 %)
15 diff
(98.4 %id)
TI_57193071   .e 101 to 950 57 to 909       853/854
(99 %)
13 diff
(98.5 %id)
TI_1948091599   .e 101 to 981 140 to 1019       880/1330
(66 %)
20 diff
(98.5 %id)
BE783802 eye, retinoblastoma .e 102 to 939 1 to 839       839/857
(97 %)
35 diff
(96.0 %id)
BQ707248 Spleen .e 102 to 945 1 to 851       851/853
(99 %)
13 diff
(98.5 %id)
EB387531 eye, optic nerve .e 102 to 954 1 to 852       852/852
(100 %)
3 diff
(99.7 %id)
EC458122 Prostate .e 103 to 206 1 to 104       104/104
(100 %)
0 diff
(100 %id)
CX787867 human embryonic stem cells .e 103 to 981 1 to 879       879/883
(99 %)
3 diff
(99.7 %id)
CR611035 Placenta Cot 25-normalized .e 104 to 1245 1 to 1142       1142/1142
(100 %)
0 diff
(100 %id)
BX417514 placenta .e 104 to 1116 1 to 1002       1002/1002
(100 %)
13 diff
(98.8 %id)
BI255093 cervical carcinoma cell line, cervix .e 104 to 981 1 to 873       873/886
(98 %)
21 diff
(97.7 %id)
BQ933676 sciatic nerve .e 104 to 912 1 to 811       811/925
(87 %)
7 diff
(99.3 %id)
BQ276342 carcinoma, cell line, Prostate .e 105 to 984 1 to 881       881/1042
(84 %)
8 diff
(99.3 %id)
BU932039 ovary, teratocarcinoma, cell line .e 105 to 1020 1 to 921       921/923
(99 %)
19 diff
(98.0 %id)
CR600240 Placenta Cot 25-normalized .e 106 to 1219 1 to 1114       1114/1114
(100 %)
0 diff
(100 %id)
CR625294 T cells (Jurkat cell line) Cot10-normalized .e 106 to 1226 1 to 1121       1121/1121
(100 %)
0 diff
(100 %id)
BX387911   .e 106 to 717 1 to 612   fully sequenced,   612/612
(100 %)
1 diff
(99.9 %id)
AW328521 cervix .e 106 to 710 12 to 616       605/616
(98 %)
7 diff
(98.9 %id)
BM012531 brain, neuroblastoma, cell line .e 107 to 981 1 to 871       869/928
(93 %)
17 diff
(98.2 %id)
TI_59381748   .e 107 to 981 63 to 933       869/928
(93 %)
17 diff
(98.2 %id)
AI174784 Liver .e 108 to 634 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BQ878641 ductal carcinoma, cell line, Pancreas .e 108 to 960 1 to 857       857/861
(99 %)
9 diff
(99.0 %id)
BQ685424 ductal carcinoma, cell line, Pancreas .e 108 to 981 1 to 879       879/889
(98 %)
23 diff
(97.5 %id)
BU070795 insulinoma, Pancreas .e 109 to 652 1 to 544   fully sequenced,   544/544
(100 %)
5 diff
(99.1 %id)
BM542978 embryonal carcinoma, cell line, testis .e 110 to 981 1 to 876       876/1071
(81 %)
13 diff
(98.8 %id)
BU195742 leiomyosarcoma, uterus .e 111 to 905 1 to 800       800/897
(89 %)
8 diff
(99.2 %id)
BG683378 brain, neuroblastoma, cell line .e 113 to 717 1 to 605   fully sequenced,   605/605
(100 %)
2 diff
(99.7 %id)
CB161262 Liver .e 114 to 617 1 to 504       504/504
(100 %)
0 diff
(100 %id)
CT003180 T-Lymphocytes .e 114 to 835 1 to 723       723/734
(98 %)
6 diff
(99.2 %id)
CN313090 embryonic stem cells, cell lines H1, H7, andH9 .e 115 to 525 1 to 411       411/411
(100 %)
0 diff
(100 %id)
BM480215 eye, retinoblastoma .e 115 to 1123 1 to 1016       1014/1066
(95 %)
26 diff
(97.6 %id)
BQ883783 brain, neuroblastoma, cell line .e 115 to 1011 1 to 899       899/899
(100 %)
11 diff
(98.8 %id)
CB161353 Liver .e 115 to 617 1 to 503       503/503
(100 %)
0 diff
(100 %id)
CR591368 fetal brain .e 122 to 1272 1 to 1151   tiling clone,   1151/1151
(100 %)
0 diff
(100 %id)
BX441467 brain, fetal brain .e 122 to 717 1 to 596   fully sequenced,   596/596
(100 %)
1 diff
(99.9 %id)
BE740262 adenocarcinoma cell line, ovary .e 126 to 973 1 to 844       844/897
(94 %)
30 diff
(96.7 %id)
BG742702 skin .e 131 to 1090 1 to 953       953/992
(96 %)
31 diff
(96.9 %id)
AA315329 colon .e 132 to 572 1 to 441       441/442
(99 %)
0 diff
(100 %id)
CR622906 Neuroblastoma Cot 25-normalized .e 171 to 1248 1 to 1078       1078/1078
(100 %)
0 diff
(100 %id)
BX375440 Neuroblastoma Cot 25-normalized .e 171 to 478 1 to 308   fully sequenced,   308/308
(100 %)
1 diff
(99.7 %id)
BG674355 skin .e 174 to 1079 1 to 910       910/910
(100 %)
18 diff
(98.1 %id)
BQ690329 ductal carcinoma, cell line, Pancreas .e 202 to 981 1 to 784       784/915
(85 %)
17 diff
(98.2 %id)
CR615338 T cells (Jurkat cell line) Cot10-normalized .e 224 to 1276 1 to 1053       1053/1053
(100 %)
0 diff
(100 %id)
AL559615 T cells from T cell leukemia .e 224 to 1231 1 to 998   fully sequenced,   998/998
(100 %)
15 diff
(98.5 %id)
BU947780 insulinoma, Pancreas .e 236 to 717 1 to 482   fully sequenced,   482/482
(100 %)
5 diff
(99.0 %id)
BU947371 insulinoma, Pancreas .e 248 to 851 8 to 611   fully sequenced,   604/611
(98 %)
6 diff
(99.1 %id)
CD611407   .e 249 to 1039 806 to 15       792/806
(98 %)
3 diff
(99.7 %id)
BG743477 skin .e 249 to 1139 1 to 891       891/924
(96 %)
13 diff
(98.6 %id)
BI083809 epidermoid carcinoma, cell line, salivary gland .e 280 to 717 1 to 438   fully sequenced,   438/438
(100 %)
1 diff
(99.8 %id)
CR593921 fetal liver .e 290 to 1274 1 to 985       985/985
(100 %)
0 diff
(100 %id)
BX405649 fetal liver, Liver .e 290 to 1273 1 to 983   fully sequenced,   983/983
(100 %)
7 diff
(99.3 %id)
BM789877 stomach .e 315 to 899 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BQ675225 epidermoid carcinoma, cell line, salivary gland .e 316 to 1224 1 to 913       913/923
(98 %)
15 diff
(98.4 %id)
BQ957181 large cell carcinoma, lung .e 326 to 1156 1 to 842       842/922
(91 %)
14 diff
(98.5 %id)
BQ049385 lymph, lymphoma, cell line .e 338 to 1162 1 to 829       829/981
(84 %)
24 diff
(97.6 %id)
BY994143   .e 347 to 1026 27 to 706       680/706
(96 %)
0 diff
(100 %id)
BU185172 ductal carcinoma, cell line, Pancreas .e 349 to 1244 1 to 894       894/995
(89 %)
27 diff
(97.3 %id)
BE739805 hypernephroma, Kidney .e 351 to 1198 850 to 1       850/958
(88 %)
20 diff
(98.0 %id)
CR610523 T cells (Jurkat cell line) Cot10-normalized .e 357 to 1244 1 to 888       888/888
(100 %)
0 diff
(100 %id)
BX366977   .e 357 to 717 1 to 361   fully sequenced,   361/361
(100 %)
0 diff
(100 %id)
BP302941   .e 360 to 940 1 to 581       581/581
(100 %)
0 diff
(100 %id)
TI_154190727   .e 364 to 988 51 to 675       625/1036
(60 %)
24 diff
(97.7 %id)
TI_149310518   .e 370 to 1274 978 to 83   AAA   899/962
(93 %)
19 diff
(98.1 %id)
BM708692 eye, RPE and Choroid .e 391 to 717 1 to 327   fully sequenced,   327/327
(100 %)
1 diff
(99.7 %id)
BP422504 small intestine .e 404 to 914 1 to 511     Submitted on the opposite strand 511/511
(100 %)
0 diff
(100 %id)
TI_149292333   .e 414 to 1274 934 to 81   AAA   854/936
(91 %)
11 diff
(98.9 %id)
AL522701 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 417 to 1123 706 to 1   fully sequenced,   706/706
(100 %)
3 diff
(99.6 %id)
BX353729 Neuroblastoma Cot 25-normalized .e 417 to 1248 845 to 16   fully sequenced,   830/845
(98 %)
6 diff
(99.3 %id)
BX375439 Neuroblastoma Cot 25-normalized .e 417 to 1223 832 to 27   fully sequenced,   806/832
(96 %)
5 diff
(99.4 %id)
AL581193 T cells from T cell leukemia .e 417 to 1225 813 to 6   fully sequenced,   808/813
(99 %)
2 diff
(99.8 %id)
BX405648 fetal liver, Liver .e 417 to 1248 832 to 1   fully sequenced,   832/832
(100 %)
13 diff
(98.5 %id)
BM694226 eye, RPE and Choroid .e 432 to 868 1 to 437   fully sequenced,   437/437
(100 %)
0 diff
(100 %id)
CR598218 Neuroblastoma Cot 25-normalized .e 438 to 1276 1 to 839       839/839
(100 %)
0 diff
(100 %id)
BQ278908 adenocarcinoma, cell line, breast .e 447 to 1274 866 to 35   AAA Submitted on the opposite strand 832/963
(86 %)
12 diff
(98.8 %id)
TI_149314279   .e 448 to 1274 905 to 84   AAA   822/1008
(81 %)
10 diff
(99.1 %id)
BE019621 carcinoma cell line, cervix .e 451 to 983 1 to 533     Submitted on the opposite strand 533/533
(100 %)
0 diff
(100 %id)
BC014786 Ovary, adenocarcinoma .e 462 to 1274 851 to 39   available from MGC, AAA Submitted on the opposite strand 813/837
(97 %)
0 diff
(100 %id)
BM974528 lung .e 558 to 1274 730 to 15   AAA   716/716
(100 %)
3 diff
(99.6 %id)
BE904377 epithelioid carcinoma, Pancreas .e 561 to 957 1 to 397       397/397
(100 %)
0 diff
(100 %id)
BU615931 Bone, Subchondral Bone .e 571 to 1274 719 to 19   AAA   701/701
(100 %)
3 diff
(99.6 %id)
BU957237 adenocarcinoma, cell line, breast .e 575 to 1274 725 to 21   AAA Submitted on the opposite strand 705/940
(75 %)
8 diff
(99.2 %id)
BU070558 insulinoma, Pancreas .e 604 to 1274 685 to 16   fully sequenced, AAA   670/670
(100 %)
3 diff
(99.6 %id)
BG489748 large cell carcinoma, lung .e 610 to 1074 1 to 465       465/465
(100 %)
0 diff
(100 %id)
CA848450 Pancreas, Purified pancreatic islet .e 615 to 1082 3 to 470       468/470
(99 %)
4 diff
(99.2 %id)
BU540957 epithelioid carcinoma cell line, Pancreas .e 625 to 1270 1 to 646   AAA   646/646
(100 %)
0 diff
(100 %id)
BU632828 cell lines, Chondrosarcoma .e 643 to 1274 646 to 15   AAA   632/632
(100 %)
0 diff
(100 %id)
BX413244 brain, fetal brain .e 656 to 1272 613 to 1   fully sequenced,   613/613
(100 %)
5 diff
(99.2 %id)
BX387910   .e 656 to 1226 571 to 1   fully sequenced,   571/571
(100 %)
2 diff
(99.7 %id)
BX366976   .e 656 to 1244 591 to 1   fully sequenced,   591/591
(100 %)
3 diff
(99.5 %id)
BF967618 brain, hypothalamus .e 656 to 1224 569 to 1   fully sequenced,   569/569
(100 %)
6 diff
(99.0 %id)
BG683977 brain, neuroblastoma, cell line .e 656 to 1226 571 to 1   fully sequenced,   571/571
(100 %)
4 diff
(99.3 %id)
BI084477 epidermoid carcinoma, cell line, salivary gland .e 656 to 1222 568 to 2   fully sequenced,   567/568
(99 %)
1 diff
(99.9 %id)
BU947514 insulinoma, Pancreas .e 656 to 1274 636 to 18   fully sequenced, AAA   619/619
(100 %)
0 diff
(100 %id)
BU731885 eye, RPE and Choroid .e 656 to 1274 637 to 19   fully sequenced, AAA   619/619
(100 %)
1 diff
(99.9 %id)
BQ638030 eye, retina .e 660 to 1118 1 to 459       459/459
(100 %)
0 diff
(100 %id)
BQ225445 epithelioid carcinoma, Pancreas .e 665 to 1276 1 to 612       612/621
(98 %)
2 diff
(99.7 %id)
BM310387 Pancreas, Purified pancreatic islet .e 693 to 1276 584 to 1       584/584
(100 %)
0 diff
(100 %id)
AI972771 Prostate .e 726 to 1273 548 to 1       548/548
(100 %)
0 diff
(100 %id)
FN090972 breast carcinoma .e 753 to 807 55 to 1     Submitted on the opposite strand 55/55
(100 %)
0 diff
(100 %id)
BQ881393 brain, neuroblastoma, cell line .e 766 to 1270 1 to 505   AAA   505/505
(100 %)
0 diff
(100 %id)
AW328522 cervix .e 785 to 1270 508 to 23   AAA   486/486
(100 %)
0 diff
(100 %id)
AI355172 lung .e 801 to 1275 475 to 1       475/475
(100 %)
0 diff
(100 %id)
FN067414 breast carcinoma .e 804 to 901 1 to 98       98/98
(100 %)
0 diff
(100 %id)
AI127101 heart .e 807 to 1275 469 to 1       469/469
(100 %)
0 diff
(100 %id)
BU786160 insulinoma, Pancreas .e 810 to 1274 482 to 18   fully sequenced, AAA   465/465
(100 %)
0 diff
(100 %id)
DB330746 skeletal muscle .e 811 to 1274 465 to 1   fully sequenced,   465/465
(100 %)
3 diff
(99.4 %id)
DB565637 hypothalamus .e 815 to 1274 1 to 460     Submitted on the opposite strand 460/460
(100 %)
0 diff
(100 %id)
BU733095 eye, RPE and Choroid .e 838 to 1274 455 to 19   fully sequenced, AAA   437/437
(100 %)
2 diff
(99.6 %id)
AW008807 colon .e 840 to 1278 439 to 1       439/439
(100 %)
0 diff
(100 %id)
FN061504 breast carcinoma .e 910 to 974 1 to 65       65/65
(100 %)
0 diff
(100 %id)
AI921050 adenocarcinoma, Pancreas .e 920 to 1274 355 to 1       355/355
(100 %)
0 diff
(100 %id)
DB373632 placenta .e 993 to 1274 282 to 1       282/282
(100 %)
5 diff
(98.3 %id)
CA848170 Pancreas, Purified pancreatic islet .e 1085 to 1273 189 to 1       189/189
(100 %)
0 diff
(100 %id)
DB486022 hypothalamus .f 1 to 424 1 to 423   tiling clone,   423/424
(99 %)
21 diff
(95.1 %id)
BI258154 cervical carcinoma cell line, cervix .f 9 to 905 1 to 898   tiling clone,   896/901
(99 %)
17 diff
(98.2 %id)
BF030317 hypernephroma, Kidney .f 12 to 578 1 to 581       581/1011
(57 %)
24 diff
(97.7 %id)
BM691296 eye, RPE and Choroid .f 18 to 663 1 to 646       646/646
(100 %)
8 diff
(98.8 %id)
BU726479 eye, RPE and Choroid .f 710 to 1271 580 to 19   tiling clone, AAA   562/562
(100 %)
2 diff
(99.7 %id)
BX365028 Placenta Cot 25-normalized .g 1 to 1065 2 to 1057 K2M D14X E15R Q16A R17A ... tiling clone,   1057/1114
(94 %)
18 diff
(98.4 %id)
AL548976 placenta, Placenta Cot 25-normalized .g 7 to 876 1 to 876   tiling clone,   870/876
(99 %)
31 diff
(96.5 %id)
BG115989 duodenal adenocarcinoma, cell line, small intestine .g 490 to 1164 1 to 691   tiling clone,   691/1016
(68 %)
46 diff
(95.5 %id)
BM708532 eye, RPE and Choroid .h 1 to 439 1 to 439   tiling clone, fully sequenced,   439/439
(100 %)
0 diff
(100 %id)
BU730830 eye, RPE and Choroid .h 378 to 996 634 to 19   tiling clone, fully sequenced, AAA   616/616
(100 %)
4 diff
(99.4 %id)
AK092828 Spleen .i 1 to 2403 2 to 2400 exact tiling clone, available from FLJ,   2400/2400
(100 %)
5 diff
(99.8 %id)
TI_57242419   .i 865 to 1411 94 to 640   tiling clone,   547/955
(57 %)
13 diff
(98.7 %id)
BI917130 brain .i 866 to 1411 1 to 546       546/861
(63 %)
9 diff
(99.0 %id)
BG290678 bladder, transitional cell papilloma, cell line .i 1073 to 1394 1 to 327       327/793
(41 %)
12 diff
(98.5 %id)
BP345370 synovial membrane .j -10 to 571 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA206386 brain .j -9 to 563 14 to 586   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA544936   .j -9 to 548 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA747884   .j -9 to 556 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA935405 Spleen .j -9 to 575 2 to 586   capped   585/587
(99 %)
1 diff
(99.9 %id)
DB123745 thymus .j -9 to 623 2 to 634   tiling clone, capped   633/633
(100 %)
0 diff
(100 %id)
BI603573 brain, hypothalamus .j 1 to 775 8 to 792       792/1018
(77 %)
23 diff
(97.8 %id)
DA600519   .j 1 to 564 5 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DB113867 thymus .j 1 to 573 5 to 577   capped   576/577
(99 %)
5 diff
(99.2 %id)
TI_45210147   .j 1 to 775 94 to 878       787/1104
(71 %)
25 diff
(97.8 %id)
DA749692   .j 1 to 560 4 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BP283330 bone marrow .j 1 to 581 2 to 582       582/583
(99 %)
2 diff
(99.7 %id)
DA984751 synovial membrane tissue from rheumatioidarthritis .j 1 to 573 3 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB007799 cervix, tumor tissue .j 1 to 566 3 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA999858 breast, tumor tissue .j 1 to 563 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB133607 thymus .j 1 to 556 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AA436966   .j 10 to 599 13 to 600       588/600
(98 %)
12 diff
(98.0 %id)
AV763546 bone marrow .j 42 to 586 55 to 596       596/637
(93 %)
15 diff
(97.7 %id)
AA406006 ovarian tumor, ovary .j 249 to 717 1 to 469       469/469
(100 %)
5 diff
(99.0 %id)
CN278707 embryonic stem cells, cell lines H1, H7, andH9 .j 475 to 1125 1 to 651       651/651
(100 %)
2 diff
(99.7 %id)
AL044077 testis .j 533 to 973 1 to 441       441/441
(100 %)
0 diff
(100 %id)
CX758750 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 544 to 1272 1 to 719   tiling clone, Submitted on the opposite strand 719/790
(91 %)
12 diff
(98.5 %id)
BQ359008 head_neck .j 631 to 982 1 to 352       352/370
(95 %)
3 diff
(99.2 %id)
AA568302   .j 635 to 1014 1 to 382       382/401
(95 %)
11 diff
(97.3 %id)
BI036489 nervous_tumor .j 664 to 823 161 to 3       159/161
(98 %)
0 diff
(100 %id)
CV811643 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 666 to 1394 1 to 732       732/895
(81 %)
19 diff
(97.9 %id)
BM551261 duodenal adenocarcinoma, cell line, small intestine .j 702 to 1573 1 to 882       882/1118
(78 %)
21 diff
(98.2 %id)
BF984291 duodenal adenocarcinoma, cell line, small intestine .j 703 to 935 1 to 232       232/232
(100 %)
1 diff
(99.6 %id)
AA255840 germinal center B cell .j 729 to 1222 1 to 493       493/493
(100 %)
3 diff
(99.4 %id)
AA332676 Embryo, 8 weeks .j 978 to 1178 1 to 201       201/201
(100 %)
1 diff
(99.6 %id)
AA176770 muscle, skeletal muscle .j 1075 to 1303 1 to 228       228/239
(95 %)
1 diff
(99.6 %id)
CN289892 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 1080 to 1774 1 to 695   tiling clone,   695/695
(100 %)
0 diff
(100 %id)
AA218705   .j 1105 to 1444 1 to 337       337/337
(100 %)
5 diff
(98.6 %id)
FN083013 breast carcinoma .j 1176 to 1278 104 to 1     Submitted on the opposite strand 104/104
(100 %)
1 diff
(99.1 %id)
BX365027 Placenta Cot 25-normalized .j 1293 to 2334 1042 to 10       1033/1160
(89 %)
0 diff
(100 %id)
BI083875 epidermoid carcinoma, cell line, salivary gland .j 1314 to 1715 1 to 405   fully sequenced,   405/405
(100 %)
2 diff
(99.6 %id)
BU180465 epidermoid carcinoma, cell line, salivary gland .j 1318 to 2074 14 to 773       760/923
(82 %)
12 diff
(98.7 %id)
TI_57197999   .j 1376 to 2145 59 to 827       769/827
(92 %)
6 diff
(99.3 %id)
BI821170 pooled brain, lung, testis .j 1381 to 2145 1 to 764       764/764
(100 %)
11 diff
(98.6 %id)
AV693239 hepatocellular carcinoma .j 1412 to 1756 1 to 342       342/345
(99 %)
7 diff
(98.0 %id)
AL573341 placenta, Placenta Cot 25-normalized .j 1423 to 2346 922 to 1       922/922
(100 %)
6 diff
(99.4 %id)
TI_149302548   .j 1452 to 2373 968 to 58   AAA   911/985
(92 %)
24 diff
(97.6 %id)
BF935257 nervous_tumor .j 1566 to 1953 392 to 4     Submitted on the opposite strand 389/392
(99 %)
0 diff
(100 %id)
AW166763 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 1571 to 2009 439 to 1       439/439
(100 %)
2 diff
(99.6 %id)
AA470057   .j 1600 to 2011 1 to 409   fully sequenced,   409/409
(100 %)
6 diff
(98.6 %id)
FN046575 breast carcinoma .j 1601 to 1676 1 to 76       76/76
(100 %)
3 diff
(96.1 %id)
AI630185 blood .j 1621 to 2109 494 to 1       494/494
(100 %)
14 diff
(97.2 %id)
BI019834 marrow .j 1658 to 2133 478 to 8       471/479
(98 %)
0 diff
(100 %id)
AL044078 testis .j 1671 to 2368 710 to 13   tiling clone,   698/713
(97 %)
0 diff
(100 %id)
BI084548 epidermoid carcinoma, cell line, salivary gland .j 1685 to 2326 642 to 1   fully sequenced,   642/642
(100 %)
14 diff
(97.9 %id)
BM703896 eye, Retina Foveal and Macular .j 1696 to 2091 5 to 400   fully sequenced,   396/400
(99 %)
5 diff
(98.8 %id)
BQ325666 colon_ins .j 1705 to 1996 309 to 10       300/309
(97 %)
0 diff
(100 %id)
AV738457 cord Blood .j 1709 to 2081 41 to 412       372/512
(72 %)
7 diff
(98.7 %id)
BM980726 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 1726 to 2373 666 to 19   AAA   648/648
(100 %)
2 diff
(99.7 %id)
BQ337407 marrow .j 1730 to 2087 398 to 44       355/398
(89 %)
0 diff
(100 %id)
AV650434 corresponding non cancerous liver tissue .j 1775 to 2414 1 to 644     Submitted on the opposite strand 644/644
(100 %)
16 diff
(97.6 %id)
BM993798 Bone, Subchondral Bone .j 1787 to 2416 636 to 1       636/678
(93 %)
9 diff
(98.7 %id)
CN479329 Bone, Subchondral Bone .j 1787 to 2416 636 to 1       636/678
(93 %)
9 diff
(98.7 %id)
AI669717 Prostate .j 1811 to 2373 563 to 1       563/563
(100 %)
1 diff
(99.9 %id)
AA319737 adrenal gland .j 1812 to 2079 1 to 268       268/268
(100 %)
0 diff
(100 %id)
FN057165 breast carcinoma .j 1829 to 1921 93 to 1     Submitted on the opposite strand 93/93
(100 %)
1 diff
(99.0 %id)
BU729716 eye, Retina Foveal and Macular .j 1837 to 2373 555 to 19   AAA   537/537
(100 %)
0 diff
(100 %id)
AA195597 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 1838 to 2075 1 to 238   fully sequenced,   238/238
(100 %)
2 diff
(99.2 %id)
DB551422 hippocampus .j 1884 to 2373 1 to 490     Submitted on the opposite strand 490/490
(100 %)
1 diff
(99.8 %id)
AI823616 2 pooled tumors (clear cell type), Kidney .j 1886 to 2406 522 to 1   tiling clone,   522/522
(100 %)
2 diff
(99.7 %id)
BE220043 carcinoid, lung .j 1886 to 2403 519 to 1       519/519
(100 %)
3 diff
(99.5 %id)
AA825741 germinal center B cell .j 1902 to 2382 482 to 1       482/482
(100 %)
1 diff
(99.8 %id)
AA682493 liver and spleen .j 1903 to 2373 472 to 1       472/472
(100 %)
1 diff
(99.8 %id)
AA527119 Ewing's sarcoma .j 1904 to 2373 492 to 21   AAA   472/472
(100 %)
13 diff
(97.3 %id)
DB522403 testis .j 1916 to 2373 1 to 461     Submitted on the opposite strand 461/461
(100 %)
1 diff
(99.8 %id)
AA938170 germinal center B cell .j 1919 to 2326 409 to 1       409/409
(100 %)
1 diff
(99.8 %id)
AI683736 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 1927 to 2376 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI681657 carcinoid, lung .j 1928 to 2398 477 to 6       472/477
(98 %)
0 diff
(100 %id)
BU854698 testis .j 1939 to 2425 1 to 494       494/934
(52 %)
8 diff
(99.2 %id)
BU570813 testis .j 1939 to 2428 1 to 495       495/1061
(46 %)
13 diff
(98.8 %id)
AI934924 2 pooled tumors (clear cell type), Kidney .j 1941 to 2398 469 to 11       459/469
(97 %)
0 diff
(100 %id)
AW513714 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 1944 to 2375 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AI280801 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .j 1952 to 2377 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AU185172 skin .j 1954 to 2358 1 to 404       404/404
(100 %)
3 diff
(99.3 %id)
AA237013 germinal center B cell .j 1954 to 2403 452 to 1       452/452
(100 %)
2 diff
(99.6 %id)
AI492105 B-cell, chronic lymphotic leukemia .j 1963 to 2402 442 to 1       442/442
(100 %)
1 diff
(99.8 %id)
AA176497 muscle, skeletal muscle .j 1969 to 2347 380 to 1       380/380
(100 %)
4 diff
(99.0 %id)
AW028903 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 1970 to 2374 405 to 1       405/409
(99 %)
0 diff
(100 %id)
FN057449 breast carcinoma .j 1971 to 2064 1 to 94       94/95
(98 %)
1 diff
(99.0 %id)
AA416992   .j 1985 to 2373 390 to 1   fully sequenced,   390/390
(100 %)
1 diff
(99.8 %id)
AI290193 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 1985 to 2373 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
AA993401   .j 1987 to 2377 391 to 1       391/391
(100 %)
3 diff
(99.3 %id)
AW075534 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .j 1989 to 2373 385 to 1       385/385
(100 %)
3 diff
(99.3 %id)
BF904567 marrow .j 1991 to 2149 159 to 1     Submitted on the opposite strand 159/159
(100 %)
4 diff
(97.5 %id)
AV743089 cord Blood .j 1992 to 2368 31 to 398   AAA   368/398
(92 %)
6 diff
(98.5 %id)
AA907256 germinal center B cell .j 2009 to 2326 317 to 1       317/317
(100 %)
1 diff
(99.7 %id)
AW054666 colon .j 2013 to 2402 391 to 2       390/391
(99 %)
0 diff
(100 %id)
AA593853 colon, colon tumor .j 2024 to 2402 373 to 1       373/373
(100 %)
4 diff
(99.0 %id)
AA401456 ovarian tumor, ovary .j 2025 to 2373 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AA605135 adrenal adenoma, adrenal gland .j 2025 to 2347 323 to 1       323/323
(100 %)
0 diff
(100 %id)
AA749276 germinal center B cell .j 2025 to 2382 358 to 1       358/358
(100 %)
0 diff
(100 %id)
AA282882 germinal center B cell .j 2026 to 2403 379 to 1       379/379
(100 %)
2 diff
(99.5 %id)
AA557533 colon .j 2026 to 2348 323 to 1       323/323
(100 %)
3 diff
(99.1 %id)
BG182300   .j 2034 to 2355 333 to 9     Submitted on the opposite strand 325/345
(94 %)
0 diff
(100 %id)
CD677999 eye, Trabecular meshwork .j 2036 to 2373 1 to 338   AAA   338/338
(100 %)
1 diff
(99.8 %id)
AA903341 leiomyosarcoma, soft tissue .j 2036 to 2412 377 to 1       377/377
(100 %)
3 diff
(99.3 %id)
AI269375 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 2040 to 2373 334 to 1       334/334
(100 %)
0 diff
(100 %id)
AA922408 squamous cell carcinoma from base of tongue, tongue .j 2041 to 2405 366 to 1       366/366
(100 %)
3 diff
(99.2 %id)
AA767934 germinal center B cell .j 2044 to 2326 283 to 1       283/283
(100 %)
0 diff
(100 %id)
AA194962 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 2045 to 2374 331 to 1   fully sequenced,   331/331
(100 %)
4 diff
(98.8 %id)
BF110932 carcinoid, lung .j 2047 to 2407 363 to 1       363/363
(100 %)
7 diff
(98.1 %id)
BE676564 B-cell, chronic lymphotic leukemia .j 2050 to 2404 356 to 1       356/356
(100 %)
3 diff
(99.2 %id)
AI926743 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 2052 to 2373 322 to 1       322/322
(100 %)
9 diff
(97.3 %id)
BM664067 eye, Retina Foveal and Macular .j 2061 to 2391 331 to 1   fully sequenced,   331/331
(100 %)
2 diff
(99.4 %id)
AI867755 pooled germ cell tumors .j 2064 to 2401 358 to 15   AAA   344/346
(99 %)
0 diff
(100 %id)
AA938477 carcinoid, lung .j 2075 to 2325 17 to 268     Submitted on the opposite strand 252/268
(94 %)
6 diff
(97.8 %id)
AW015908   .j 2075 to 2415 348 to 1       348/358
(97 %)
9 diff
(97.5 %id)
AI671728 Kidney .j 2111 to 2373 263 to 1       263/263
(100 %)
1 diff
(99.7 %id)
AA714846 germinal center B cell .j 2143 to 2326 184 to 1       184/184
(100 %)
0 diff
(100 %id)
AI933913 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 2145 to 2373 232 to 1       232/232
(100 %)
6 diff
(97.5 %id)
AK094966 hippocampus .j 2168 to 5261 1 to 3096 E179G tiling clone, available from FLJ,   3096/3096
(100 %)
9 diff
(99.8 %id)
DA289393 hippocampus .j 2169 to 2727 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
AA885689 carcinoid, lung .j 2193 to 2403 212 to 1       212/212
(100 %)
3 diff
(98.6 %id)
AW242270 adenocarcinoma, Pancreas .j 2193 to 2374 182 to 1       182/182
(100 %)
4 diff
(97.9 %id)
ES315158 occipital scalp hair, skin .j 2239 to 2373 154 to 20   AAA Submitted on the opposite strand 135/135
(100 %)
0 diff
(100 %id)
AA731624 germinal center B cell .j 2251 to 2412 163 to 1       163/163
(100 %)
2 diff
(98.8 %id)
AW613888 2 pooled high-grade transitional celltumors, genitourinary tract .j 2254 to 2403 151 to 1       151/152
(99 %)
3 diff
(98.1 %id)
CA311988 Human Lung Epithelial cells, lung .j 2285 to 2750 487 to 19   AAA   469/510
(91 %)
2 diff
(99.7 %id)
CA502971 Human Lung Epithelial cells, lung .j 2285 to 2750 487 to 19   AAA   469/511
(91 %)
2 diff
(99.7 %id)
AA761887 germinal center B cell .j 2287 to 2382 96 to 1       96/96
(100 %)
0 diff
(100 %id)
AA326594 brain, cerebellum .j 2323 to 2830 1 to 510       510/512
(99 %)
9 diff
(98.3 %id)
BQ880362 dorsal root ganglia .j 2374 to 3006 635 to 1     Submitted on the opposite strand 635/636
(99 %)
0 diff
(100 %id)
BF361179 ovary .j 2377 to 2700 325 to 1       325/325
(100 %)
4 diff
(98.8 %id)
BQ358638 head_neck .j 2421 to 2967 15 to 561       547/561
(97 %)
6 diff
(99.0 %id)
BF361180 ovary .j 2463 to 2700 252 to 12       241/252
(95 %)
0 diff
(100 %id)
CV355033 lung_tumor .j 2609 to 2793 187 to 1     Submitted on the opposite strand 187/187
(100 %)
16 diff
(91.5 %id)
CV355963 marrow .j 2609 to 2797 211 to 25     Submitted on the opposite strand 187/211
(88 %)
0 diff
(100 %id)
BF800431 colon_ins .j 2742 to 3060 1 to 320       320/320
(100 %)
23 diff
(92.9 %id)
DA931145 Spleen .j 2748 to 3460 2 to 714   capped   713/715
(99 %)
6 diff
(99.2 %id)
BF904301 marrow .j 2799 to 3293 495 to 1     Submitted on the opposite strand 495/495
(100 %)
7 diff
(98.6 %id)
BG960625 colon .j 2821 to 3082 263 to 4       260/263
(98 %)
0 diff
(100 %id)
BI030887 marrow .j 2821 to 3088 1 to 268       268/268
(100 %)
2 diff
(99.3 %id)
BI028101 marrow .j 2901 to 3287 386 to 2       385/444
(86 %)
0 diff
(100 %id)
BX644631   .j 2913 to 3651 11 to 750   tiling clone,   740/750
(98 %)
6 diff
(99.2 %id)
AI800860 pooled .j 3035 to 3338 421 to 118       304/421
(72 %)
0 diff
(100 %id)
BQ364247 stomach .j 3041 to 3358 331 to 14       318/334
(95 %)
0 diff
(100 %id)
BQ364388 stomach .j 3050 to 3311 14 to 280       267/280
(95 %)
6 diff
(97.9 %id)
AW813299 stomach .j 3051 to 3366 12 to 325       314/334
(94 %)
6 diff
(98.3 %id)
CD558166 White Matter .j 3157 to 3907 23 to 785       763/946
(80 %)
35 diff
(96.4 %id)
DA262919 caudate nucleus .j 3304 to 3858 2 to 556   tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
DB143152 thymus .j 3350 to 3823 2 to 475   capped   474/474
(100 %)
0 diff
(100 %id)
CA488139   .j 3569 to 4259 1 to 693   tiling clone,   693/956
(72 %)
14 diff
(98.6 %id)
BQ050958 leiomyosarcoma, uterus .j 4018 to 4522 12 to 520       509/1186
(42 %)
27 diff
(97.8 %id)
DB332352 Spleen .j 4783 to 5261 476 to 1   tiling clone,   476/486
(97 %)
6 diff
(98.8 %id)
TI_151796017   .k 1 to 634 69 to 704   tiling clone,   641/738
(86 %)
7 diff
(99.1 %id)
AL532416 brain, fetal liver, Liver, neuroblastoma cells .k 5 to 628 1 to 624   tiling clone, fully sequenced,   624/624
(100 %)
1 diff
(99.9 %id)
AL564379 brain, fetal liver, Liver, neuroblastoma cells .k 567 to 1427 862 to 6   tiling clone, fully sequenced,   857/862
(99 %)
11 diff
(98.8 %id)
BU607346 Human Lung Epithelial cells, lung .k 754 to 1461 722 to 15   tiling clone, AAA   708/708
(100 %)
0 diff
(100 %id)
BU608053 Human Lung Epithelial cells, lung .k 758 to 1461 715 to 15   AAA   701/703
(99 %)
3 diff
(99.6 %id)
AI744909 ovary, tumor, 5 pooled (see description) .k 984 to 1460 477 to 1       477/477
(100 %)
0 diff
(100 %id)
F18477 pectoral muscle (after mastectomy) .k 1175 to 1458 1 to 284       284/284
(100 %)
0 diff
(100 %id)
EC529525 Prostate .k 1176 to 1269 1 to 94       94/94
(100 %)
0 diff
(100 %id)
AW081875 esophagus, squamous cell carcinoma .k 1187 to 1457 271 to 1       271/271
(100 %)
0 diff
(100 %id)
F31372 pectoral muscle (after mastectomy) .k 1188 to 1445 1 to 258       258/258
(100 %)
0 diff
(100 %id)
AA349203 adrenal gland .k 1189 to 1461 1 to 273       273/273
(100 %)
0 diff
(100 %id)
AI739419 colon, colon tumor, RER+ .k 1190 to 1460 271 to 1       271/271
(100 %)
0 diff
(100 %id)
BE893804 melanotic melanoma, skin .k 1193 to 1455 1 to 263       263/263
(100 %)
0 diff
(100 %id)
EC471827 Prostate .k 1198 to 1310 1 to 113       113/113
(100 %)
0 diff
(100 %id)
AI718394 colon .k 1230 to 1457 228 to 1       228/228
(100 %)
0 diff
(100 %id)
AA338724 brain .k 1246 to 1457 212 to 1       212/212
(100 %)
0 diff
(100 %id)
TI_151709329   .k 1252 to 1462 314 to 104       211/299
(70 %)
0 diff
(100 %id)
EC491042 Prostate .k 1257 to 1362 1 to 106       106/106
(100 %)
0 diff
(100 %id)
AI185473 lung .k 1258 to 1461 204 to 1       204/204
(100 %)
0 diff
(100 %id)
AI424676 brain, glioblastoma (pooled) .k 1263 to 1452 190 to 1       190/190
(100 %)
0 diff
(100 %id)
AI701188 adenocarcinoma, Pancreas .k 1272 to 1461 190 to 1       190/190
(100 %)
0 diff
(100 %id)
BF149125 skin .k 1303 to 1457 1 to 155   AAA   155/155
(100 %)
0 diff
(100 %id)
EC528223 Prostate .k 1319 to 1424 1 to 106       106/106
(100 %)
0 diff
(100 %id)
AI581809 colon .k 1340 to 1452 113 to 1       113/114
(99 %)
0 diff
(100 %id)
EC462334 Prostate .k 1397 to 1463 1 to 67   tiling clone,   67/67
(100 %)
0 diff
(100 %id)
DA911599   .l 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
4 diff
(99.3 %id)
CB112936 Liver .l 2 to 487 1 to 486   tiling clone,   486/486
(100 %)
3 diff
(99.4 %id)
AA873700 2 pooled tumors (clear cell type), Kidney .l 417 to 852 447 to 11   tiling clone, AAA   437/437
(100 %)
5 diff
(98.9 %id)
TI_45235978   .m 1 to 563 63 to 624   tiling clone, fully sequenced,   562/624
(90 %)
12 diff
(98.1 %id)
TI_45235979   .m 531 to 1122 643 to 17   tiling clone, fully sequenced,   557/573
(97 %)
38 diff
(93.4 %id)
BF341643 brain, glioblastoma with EGFR amplification .n 1 to 765 14 to 774   tiling clone,   762/819
(93 %)
24 diff
(97.1 %id)
DA360793 subthalamic nucleus .n 1 to 554 2 to 556   tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
BX383109   .n 5 to 917 1 to 904   tiling clone, AAA   904/958
(94 %)
31 diff
(96.8 %id)
BF342098 brain, glioblastoma with EGFR amplification .n 15 to 697 1 to 684       684/1048
(65 %)
9 diff
(99.2 %id)
BQ437897 leiomyosarcoma, uterus .n 15 to 848 1 to 837   tiling clone,   837/896
(93 %)
21 diff
(97.7 %id)
AW771808 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .n 879 to 1349 482 to 11   tiling clone, AAA   472/476
(99 %)
14 diff
(97.1 %id)
W86897 liver and spleen .n 935 to 1349 416 to 1   tiling clone,   416/417
(99 %)
5 diff
(98.9 %id)
BX378442 Placenta Cot 25-normalized .n 961 to 1351 1 to 391   tiling clone,   391/391
(100 %)
0 diff
(100 %id)
BG494351 lung, mucoepidermoid carcinoma .o 1 to 613 1 to 613   tiling clone,   613/613
(100 %)
4 diff
(99.4 %id)
DB494586 hypothalamus .o 153 to 659 1 to 507       507/511
(99 %)
3 diff
(99.5 %id)
TI_154162587   .o 156 to 707 77 to 628       552/1267
(43 %)
3 diff
(99.8 %id)
DC338182 subthalamic nucleus .o 187 to 739 1 to 555   tiling clone,   555/555
(100 %)
2 diff
(99.7 %id)
AK301211 Spleen .o 217 to 1223 1 to 1007 E41A F168L tiling clone,   1007/1007
(100 %)
2 diff
(99.9 %id)
DC391076 Spleen .o 217 to 757 1 to 543       543/543
(100 %)
4 diff
(99.3 %id)
TI_57148137   .o 243 to 964 32 to 750       719/975
(73 %)
10 diff
(99.0 %id)
BI760366 pooled colon, kidney, stomach .o 249 to 964 1 to 714       714/939
(76 %)
4 diff
(99.6 %id)
DA929530 small intestine .p 1 to 559 2 to 562   tiling clone, capped   561/561
(100 %)
3 diff
(99.5 %id)
CN313096 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p 35 to 587 1 to 553   tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
DB328992 placenta .q 1 to 520 1 to 521   tiling clone, Submitted on the opposite strand 521/521
(100 %)
2 diff
(99.7 %id)
DN990221 brain, whole brain .q 114 to 699 8 to 592   tiling clone,   585/592
(98 %)
6 diff
(99.0 %id)
CV335717 colon_ins .q 135 to 699 565 to 1     Submitted on the opposite strand 565/565
(100 %)
8 diff
(98.6 %id)
AK097975 thymus .q 193 to 2314 1 to 2119 exact tiling clone, available from FLJ,   2119/2119
(100 %)
2 diff
(100.0 %id)
DB114261 thymus .q 194 to 755 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB114854 thymus .q 315 to 860 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA122446 cerebellum .q 587 to 1144 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BE093123 breast .q 1727 to 2034 12 to 319       308/326
(94 %)
1 diff
(99.7 %id)
DB343539 thymus .q 1744 to 2314 568 to 1   tiling clone,   568/568
(100 %)
1 diff
(99.9 %id)
AY927543   .r 1 to 342 342 to 1 exact tiling clone, Submitted on the opposite strand 342/342
(100 %)
0 diff
(100 %id)
AW795021 uterus .r 82 to 228 1 to 146       146/148
(98 %)
2 diff
(98.7 %id)
FN063100 breast carcinoma .r 270 to 335 1 to 63       63/63
(100 %)
3 diff
(95.3 %id)
BI061643 uterus_tumor .s 1 to 343 343 to 1 exact tiling clone,   343/343
(100 %)
1 diff
(99.8 %id)
CN278697 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .t 1 to 449 1 to 446 S2R S3P tiling clone,   446/446
(100 %)
7 diff
(98.5 %id)
BF435960 pooled .t 25 to 570 556 to 15   tiling clone, AAA   542/542
(100 %)
5 diff
(99.1 %id)
AY927544   .u 1 to 447 1 to 447 exact tiling clone,   447/447
(100 %)
0 diff
(100 %id)
BF173496 blood .va-u 1 to 376 1 to 376   tiling clone,   376/377
(99 %)
5 diff
(98.7 %id)
BQ707451 Spleen .va-u 98 to 918 1 to 838   tiling clone,   838/978
(85 %)
28 diff
(97.2 %id)
BQ710774 Spleen .va-u 98 to 847 1 to 761   tiling clone,   761/923
(82 %)
28 diff
(97.0 %id)
AA359070 lung .va-u 186 to 462 1 to 278       278/278
(100 %)
2 diff
(99.3 %id)
AJ706035 bone marrow .va-u 234 to 577 1 to 344       344/344
(100 %)
5 diff
(98.6 %id)
DW409228 Liver .va-u 352 to 680 16 to 339       324/339
(95 %)
6 diff
(98.3 %id)
DW465329 Liver .va-u 857 to 1192 17 to 351   tiling clone,   335/358
(93 %)
14 diff
(96.1 %id)
BF772986 epid_tumor .va-u 880 to 1212 2 to 337   tiling clone,   336/338
(99 %)
14 diff
(95.9 %id)
BI038537 nervous_tumor .va-u 1091 to 1432 129 to 467   tiling clone,   339/467
(72 %)
6 diff
(98.8 %id)
BI039860 nervous_tumor .va-u 1091 to 1432 343 to 1   tiling clone,   343/444
(77 %)
2 diff
(99.6 %id)
BE844027 testis_normal .va-u 1241 to 1753 527 to 16   tiling clone,   512/527
(97 %)
0 diff
(100 %id)
BF373853 stomach_normal .va-u 1381 to 1824 464 to 19   tiling clone,   446/473
(94 %)
0 diff
(100 %id)
AW863671 stomach_normal .va-u 1389 to 1820 449 to 19   tiling clone,   431/451
(95 %)
0 diff
(100 %id)
AL602906 human skeletal muscle .vb-u 497 to 1043 1 to 546   tiling clone,   546/546
(100 %)
2 diff
(99.7 %id)
BF746729 breast .vb-u 523 to 944 13 to 433   tiling clone,   421/433
(97 %)
6 diff
(98.7 %id)
EC469915 Prostate .vb-u 586 to 687 1 to 102       102/102
(100 %)
5 diff
(95.1 %id)
EC441692 Prostate .vb-u 589 to 687 1 to 99       99/99
(100 %)
0 diff
(100 %id)
EC554492 Prostate .vb-u 603 to 693 18 to 109       92/109
(84 %)
6 diff
(94.5 %id)
CR975761 T-Lymphocytes .vb-u 914 to 1421 1 to 509 exact tiling clone,   509/509
(100 %)
1 diff
(99.9 %id)
CN278692 embryonic stem cells, DMSO-treated H9 cellline .vc 1 to 624 9 to 632 exact tiling clone,   624/632
(98 %)
6 diff
(99.1 %id)
BU617779 Bone, Subchondral Bone .vd 1 to 585 598 to 14 L27* tiling clone, AAA   585/585
(100 %)
12 diff
(98.0 %id)
BI062906 uterus_tumor .ve 1 to 356 356 to 1 exact tiling clone,   356/356
(100 %)
0 diff
(100 %id)
BG960911 colon .vf 1 to 196 220 to 23 D5E Q6S D7G T8Y W9I ... tiling clone,   198/222
(89 %)
3 diff
(98.7 %id)
CV367954 colon .vf 2 to 196 224 to 24 F2S Q6P D7G T8Y W9C ... tiling clone, Submitted on the opposite strand 201/224
(89 %)
8 diff
(96.5 %id)
R23534 whole brain Gene HNRNPLandECH1, variant not shown              
R44284 whole brain Gene HNRNPLandECH1, variant not shown              
AA088707 colon, tumor Gene HNRNPLandECH1, variant not shown              
AA088773 colon, tumor Gene HNRNPLandECH1, variant not shown              
BU151519 ductal carcinoma, cell line, Pancreas Gene HNRNPLandECH1, variant not shown         Submitted on the opposite strand    
175 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb-u, .vc, .vd, .ve, .vf Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI